NDATOPICALCREAM
Approved
Dec 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MENTAX (butenafine hydrochloride) is a topical antifungal cream approved in 1996 for the treatment of tinea pedis (athlete's foot). It is a small-molecule fungistatic agent that disrupts fungal cell membrane integrity by inhibiting sterol synthesis. The drug is administered topically and represents a mature, established therapy in the dermatology space.
LOE Approaching
MENTAX faces significant competitive pressure (30/100) with declining spending ($10K), indicating a mature product in defensive maintenance mode requiring cost-control and portfolio optimization strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS
Started Jan 2019
42 enrolled
Tinea Pedis
Career Relevance
Working on MENTAX as a pharma professional typically involves roles in product maintenance, channel management, and transition planning rather than growth or innovation. This is a suitable position for professionals seeking stability in a mature portfolio or for those building experience before transitioning to higher-growth products.
Brand Manager
Worked on MENTAX at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.